investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Role of p21 Activated Kinase in Leukemogenesis
Reuben Kapur
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Xin Wang
Dana-Farber Cancer Institute
Boston, United States
University of Manchester
Manchester, United Kingdom
Reuben Kapur
Indiana University – Purdue University Indianapolis
Indianapolis, United States
Related projects
Robert Stanley
Investigating the role of ARC in hematopoiesis and myeloproliferative neoplasms
Leukaemia
Hematology and hematologic malignancies
Marina Y Konopleva
Hypoxia-Selective Kinase Inhibitors for Leukemia Therapy
Leukaemia
Hematology and hematologic malignancies
Joseph L Wiemels
Genome-Wide Association Study of Childhood Leukemia by Hispanic Status
Leukaemia
Hematology and hematologic malignancies
Peter Aplan
Collaborative Pathways that Lead to Leukemia
Leukaemia
Hematology and hematologic malignancies
Alan B. Cantor
Regulation of RUNX1 Multiprotein Complex Formation during Hematopoiesis
Leukaemia
Hematology and hematologic malignancies
Bruce R Blazar
Cytotoxic-T-Lymphocyte (CTL) Therapy of Acute Myeloid Leukemia (AML)
Leukaemia
Hematology and hematologic malignancies
Andrew G Myers
Synthesis and Study of Natural and Non-natural Antiproliferative Agents
Leukaemia
Hematology and hematologic malignancies
Monica J Justice
The Pluripotency Regulator Prdm14 Initiates Cancer by Epigenetic Mechanisms
Leukaemia
Hematology and hematologic malignancies
Richard Aplenc
Genetic Predictors of AML Treatment Response
Leukaemia
Hematology and hematologic malignancies